Recipharm in Commercial Supply Pact
By

By
Recipharm has formed a collaboration with Laccure, a Helsingborg, Sweden-based project company within the life-science development company, Partners for Development Investments in Life Sciences, for the commercial manufacture and delivery…

Shire in Supply Pact with AMRI
By

By
Shire has formed a multi-year supply agreement with Albany Molecular Research Inc. (AMRI) for an undisclosed product. The terms of the agreement were kept confidential. This is the second such…

Roche, MilliporeSigma Expand Distribution Deal
By

By
Roche has expanded its distribution agreement with MilliporeSigma, the life sciences business of Merck KGaA, to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of…

AstraZeneca Completes $330-Million Divestment of Respiratory Drug to J&J
By

By
AstraZeneca has completed its previously announced agreement to divest the rights to Rhinocort Aqua (budesonide) nasal spray outside the US to Cilag GmbH International, an affiliate of Johnson & Johnson.…

Celgene to Acquire Acetylon as New Startup is Spun Out
By

By
Celgene has agreed to acquire Acetylon Pharmaceuticals, a Boston-based company specializing in cancer therapeutics. Prior to the acquisition, Acetylon will spin out a new company, Regenacy Pharmaceuticals, LLC, which will…

Takeda Launches New Company for Neurology Drugs
By

By
Takeda Pharmaceutical and Lightstone Ventures, a Menlo Park, California-based investment firm, have launched a new neuroscience-focused company named Cerevance to discover and develop therapeutics for neurological and psychiatric disorders. Cerevance…

Pfizer, IBM in Immuno-Oncology Research Using Cloud-Based System
By

By
Pfizer has formed a collaboration with IBM Watson Health that will use the Watson for Drug Discovery cloud-based cognitive tool for research into immuno-oncology. Pfizer will customize the cloud-based cognitive…

Sanofi, JHL Biotech in Biosimilars Pact for China
By

By
Sanofi has formed an alliance with JHL Biotech, a Taiwan-based biopharmaceutical company, to develop and commercialize biosimilars in China, with potential for international expansion. Under the agreement, Sanofi will invest…

AbbVie in Cancer Research Pacts with Johns Hopkins, Northwestern
By

By
AbbVie has signed five-year research and discovery (R&D) agreements each with Johns Hopkins University School of Medicine and Northwestern University for oncology R&D. Both collaborations will focus on several areas…

Ariad, Endo, Lilly, and Teva Lead Drug Approvals
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Endo, Eli Lilly and Company, and Teva as well as Ariad Pharmaceuticals. Editor’s Note: This article…